跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Letrosaph
Approved
STANDARD
Letrosaph
Bruck Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e6ae41d1b76debaf
Company
Bruck Pharma Private Limited
Type
Standard
Approval Details
Approval Id
e6ae41d1b76debaf
Drug Approval Philippines Name
Letrosaph
Product Name
Letrosaph
Registration Number
DRP-13836
Brand Name
Letrosaph
Generic Name
Letrozole
Dosage Form
Film-Coated Tablet
Dosage Strength
2.5 mg
Manufacturer
Bruck Pharma Private Limited
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
27 April 2023
Expiry Date
08 February 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e6ae41d1b76debaf
Type
Standard
Back to Philippines FDA Approvals
Letrosaph - Philippines FDA Drug Approval Details